Concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: Is intergroup study 0099 feasible in Japanese patients?

Japanese Journal of Clinical Oncology

Volumn 33, Issue 10, 2003, Pages 497-500

  Isobe, Koichi ^a,b   Kawakami, Hiroyuki ^a   Uno, Takashi ^a   Yasuda, Shigeo ^a   Aruga, Takashi ^a   Ueno, Naoyuki ^a   Kawata, Tetsuya ^a   Ito, Hisao ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b NONE   (Japan)

Author keywords

Concurrent chemoradiotherapy; Feasibility; Intergroup study 0099; NPC

Indexed keywords

CISPLATIN; FLUOROURACIL; SEROTONIN ANTAGONIST; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; ASIAN; BLOOD TOXICITY; BODY WEIGHT DISORDER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL PROTOCOL; DERMATITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; HUMAN; JAPAN; MALE; NASOPHARYNX CARCINOMA; NAUSEA; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PHARYNGITIS; RADIATION RESPONSE; SKIN MANIFESTATION; TREATMENT PLANNING; UNITED STATES; VOMITING; WEIGHT REDUCTION; ADJUVANT CHEMOTHERAPY; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; FEASIBILITY STUDY; MIDDLE AGED; NASOPHARYNX TUMOR; RADIATION DOSE FRACTIONATION;

ADULT; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEGLUTITION DISORDERS; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PHARYNGITIS;

EID: 0642372943     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg094     Document Type: Article

References (24)

1. Ngan RKC, Yiu HHY, Lau WH, Yau S, Cheung FY, Chan TM, et al. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: Report of a phase II study. Ann Oncol 2002;13:1252-8.
2. Taamma A, Fandi A, Azli N, Wibault P, Chouaki N, Hasbini A, et al. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer 1999;86: 1101-8.
3. Siu LL, Czaykowski PM, Tannock IF. Phase I/II study of the CAPBLE regimen for patients with poorly differentiated carcinoma of the nasopharynx. J Clin Oncol 1998;16:2514-21.
4. Fnadi A, Altun M, Azli N, Armand JP, Cvitkovic E. Nasopharyngeal cancer, epidemiology, staging and treatment. Semin Oncol 1994;21:382-97.
5. Chua DTT, Sham JST, Choy D, Kwong DLW, Au GKH, Kwong PWK, et al. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: The Queen Mary Hospital experience. Int J Radiat Oncol Biol Phys 2001;49:1219-28.
6. Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1350-7.
7. Chan ATC, Teo PML, Leung TWT, Leung SF, Lee WY, Yeo W, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995;33:569-77.
8. Rossi A, Molinari R, Boracchi P, Del Vecchio M, Marubini E, Nava M, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988;6: 1401-10.
9. Al-Saraf M, LeBlanc M, Giri PGS, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol 1998;16:1310-7.
10. Al-Saraf M, LeBlanc M, Giri PGS, Fu KK, Cooper J, Vuong T, et al. Superiority of five year survival with chemo-radiotherapy (CT-RT) vs radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: Final Report (abstract #905). Proc Am Soc Clin Oncol 2001;20: 227a.
11. Chan ATC, Teo PML, Ngan RK, Leung TW, Lau WH, Zee LB, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A progression free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20: 2038-44.
12. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-7.
13. Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma. Am J Clin Oncol 2002;25:219-23.
14. Fuwa N, Kano M, Toita T, Shikama N, Kodaira T, Matsumoto A, et al. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: A preliminary report of phase II study. Radiother Oncol 2001;61:257-60.
15. Benasso M, Sanguineti G, D'Amico M, Corvo R, Ricci I, Numico G, et al. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. Br J Cancer 2000; 83:1437-42.
16. Levendag PC, Lagerwaard FJ, Noever I, de Pan C, van Nimwegen A, Wijers O, et al. Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx. Int J Radiat Oncol Biol Phys 2002; 52:755-68.
17. Jian JJM, Cheng SH, Tsai SYC, Yen KCL, Chu NM, Chan KY, et al. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2002;53:344-52.
18. Rischin D, Corry J, Smith J, Stewart J, Hughes P, Peters L. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol 2002;20:1845-52.
19. Wolden SL, Zelefsky MJ, Kraus DH, Rosenweig KE, Chong LM, Shaha AR, et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1105-10.
20. Chong SH, Yen KL, Jian JJM, Tsai SYC, Chu NM, Leu SY, et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: Impact on future clinical trials. Int J Radiat Oncol Biol Phys 2001;50:717-26.
21. Tan EH, Chua ET, Wee J, Tan T, Fong KW, Ang PT, et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: Toxicities and preliminary results. Int J Radiat Oncol Biol Phys 1999;45:597-601.
22. Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J, et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol 2002;63:269-74.
23. Chua DTT, Sham JST, Au GKH, Choy D. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: Results of a matched cohort analysis. Int J Radiat Oncol Biol Phys 2002;53:334-43.
24. Baron-Hay S, Clifford A, Jackson M, Clarke S. Life threatening laryngeal toxicity following treatment with combined chemoradiotherapy for nasopharyngeal cancer: A case report with review of literature. Ann Oncol 1999;10:1109-12.